Share This Author
Adult haemophagocytic syndrome
Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year Period: A Comparison of Early and Late Manifestations in a Cohort of 1,000 Patients
Most of the SLE inflammatory manifestations appear to be less common after a long-term evolution of the disease, probably reflecting the effect of therapy as well as the progressive remission of the Disease in many patients.
Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review
- G. Ruiz-Irastorza, M. Ramos-Casals, P. Brito-Zerón, M. Khamashta
- MedicineAnnals of the rheumatic diseases
- 22 December 2008
High levels of evidence were found that AMs prevent lupus flares and increase long-term survival of patients with SLE; moderate evidence of protection against irreversible organ damage, thrombosis and bone mass loss and evidence supporting an effect on severe l upus activity, lipid levels and subclinical atherosclerosis was weak.
EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjögren's syndrome
The EULAR SS Patient Reported Index is a very simple index designed to measure patients' symptoms in primary SS and has good construct validity and is well correlated with SSI and PROFAD.
Autoimmune Diseases Induced by TNF-Targeted Therapies: Analysis of 233 Cases
The use of anti-TNF agents has been associated with an increasing number of cases of autoimmune diseases, principally cutaneous vasculitis, lupus-like syndrome, SLE, and interstitial lung disease.
Primary Sjögren Syndrome in Spain: Clinical and Immunologic Expression in 1010 Patients
Primary SS should be considered as a systemic autoimmune disease that can express in many guises beyond sicca involvement and have a significant impact on the clinical presentation of primary SS, influencing the results of the main diagnostic tests, the prevalence and diversity of extraglandular involvement, and the frequency of themain immunologic markers.
The clinical spectrum of IgG4-related disease.
Catastrophic Antiphospholipid Syndrome: Clues to the Pathogenesis from a Series of 80 Patients
The clinical and serologic features of the largest series of patients with catastrophic APS hitherto reported are described, including 30 new cases from interested physicians in many different countries, as well as a comprehensive literature review of 50 additional recently published case reports with this syndrome.
Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases.
EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide
A user guide for the ESSDAI is provided, which provides definitions and precisions on the rating of each domain, and includes some minor improvement of the score to integrate advance in knowledge of disease manifestations.